MAY:LSEMayflower Acquisition Ltd. Analysis
Data as of 2026-03-10 - not real-time
$9.75
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Mayflower Acquisition Limited (MAY.L) is trading at a flat $9.75, exactly at its identified support level, suggesting limited upside unless a breakout occurs. The stock sits below its 20‑day SMA of 9.89 and the 50‑day SMA of 10.12, reinforcing a short‑term bearish bias. However, the MACD histogram has turned positive and the MACD signal is flagged as bullish, hinting at a possible technical reversal. RSI is at 36, still above the oversold threshold of 30, indicating modest buying pressure but not a strong rebound yet. Volume trends are decreasing, with average daily volume far below the 10‑day average, which may limit price discovery. Volatility over the past 30 days is elevated at ≈ 17.8%, and the beta of ‑0.12 suggests the stock moves independently of broader market swings.
The company reports zero revenue, earnings, or cash balances, reflecting its status as a newly incorporated shell awaiting a merger or acquisition. Consequently, traditional valuation multiples are unavailable, and the market cap of ≈ $480 million appears speculative. The fear‑and‑greed index reads 76.9, labeled Extreme Greed, implying market participants may be over‑optimistic despite limited fundamentals. The maximum drawdown of ‑11.4% and a bearish trend direction further underscore the downside risk. Given the lack of dividend policy and the uncertainty surrounding a future business combination, dividend sustainability is effectively false. Investors should weigh the technical hints of a rebound against the structural uncertainties before deciding on exposure.
The company reports zero revenue, earnings, or cash balances, reflecting its status as a newly incorporated shell awaiting a merger or acquisition. Consequently, traditional valuation multiples are unavailable, and the market cap of ≈ $480 million appears speculative. The fear‑and‑greed index reads 76.9, labeled Extreme Greed, implying market participants may be over‑optimistic despite limited fundamentals. The maximum drawdown of ‑11.4% and a bearish trend direction further underscore the downside risk. Given the lack of dividend policy and the uncertainty surrounding a future business combination, dividend sustainability is effectively false. Investors should weigh the technical hints of a rebound against the structural uncertainties before deciding on exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price at support level
- decreasing volume
- bearish SMA alignment
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential MACD reversal
- absence of financial fundamentals
- elevated volatility
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- possibility of a merger or acquisition
- shell structure offering upside
- market sentiment reflected by extreme greed
Key Metrics & Analysis
Financial Health
Industry P/E17.3
Technical Analysis
TrendBearish
RSI36.3
Support$9.75
Resistance$10.50
MA 20$9.89
MA 50$10.12
MA 200$10.22
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.12
Volatility17.77%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.